IMAGIN MOLECULAR CP

http://quotes.freerealtime.com/rt/frt/M?IM=quotes&symbol=IMGM&type=News da läuft mal wieder ne schöne Public Relation Tour,als nächstes kommt bestimmt Pennystockraketen wieder

Ob da jemand etwas weiß?

+20%

Imagin's solution and approach represents the inevitable shift from traditional methods of coronary disease management to less invasive imaging followed by non-surgical therapies. Imagin, through its Coronary Disease Reversal and Prevention Centers, is positioned to be the first company to offer such techniques to larger companies as a solution to their largest expenditure of healthcare dollars. Joseph Oliverio, CEO of Imagin states, "Imagin's access to data and execution model will position Imagin to be the logical choice of coronary disease management contracts from self-insured large corporations. Imagin will be the first to demonstrate benefits with real patient data that will prove substantial patient and economic improvements much greater than the current practice. In the past, studies have only demonstrated theory through econometric data without the clinical applications and results that Imagin possess. With cooperation from Positron Corporation, we will be able to deliver affordable PET and PET / CT devices for widespread distribution to Imagin supported centers markets. In addition Positron Corporation is currently implementing innovative software solutions specific to the coronary disease reversal and prevention market further positioning them to be the market leader in the industry."